Search Results - "Silva Prado, Douglas"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    NLRP12 controls arthritis severity by acting as a checkpoint inhibitor of Th17 cell differentiation by Prado, Douglas Silva, Veras, Flavio P., Ferreira, Raphael Gomes, Damasceno, Luis Eduardo Alves, Melo, Paulo Henrique, Zamboni, Dario Simões, Cunha, Thiago Mattar, Cunha, Fernando Queiroz, Alves‐Filho, José Carlos

    Published in The FASEB journal (01-08-2020)
    “…Nucleotide oligomerization domain (NOD)‐like receptor‐12 (NLRP12) has emerged as a negative regulator of inflammation. It is well described that the Th17 cell…”
    Get full text
    Journal Article
  10. 10
  11. 11

    PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice by Sonego, Andreza Buzolin, Prado, Douglas da Silva, Guimarães, Francisco Silveira

    “…Tardive dyskinesia (TD) is a movement disorder that appears after chronic use of drugs that block dopaminergic receptors such as antipsychotics. Besides the…”
    Get full text
    Journal Article
  12. 12

    Abstract 770: Negative regulation of the CCL22/CCR4 axis by TNFR1 improves melanoma outcome by Leite, Caio Abner, Melo, Paulo Henrique, Mota, Jose Mauricio, Prado, Douglas Silva, Viacava, Paula Ramos, Cunha, Fernando Queiroz, Alves Filho, Jose Carlos

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Purpose: Immunotherapy for melanoma skin cancer is mainly focused on preventing T cell deactivation through PD1 or CTLA4 inhibition. Another proposed mechanism…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15